Product search
Filter
Search results
Aprotinin
Aprotinin can be used in any application where inhibition of its targeted proteases is needed. Current uses include protein isolation, removal of reactive proteases through solid phase, inhibition of undesired proteolytic activity in laboratory assays, or other techniques; for blocking fibrinolytic activity in vitro; etc.
Arachidonic Acid
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Bioactive HIT-Like Control Plasma
The Bioactive HIT-Like Control Plasma is intended for the quality control of HIT assays. This kit is for research use only and must not be used for patient diagnosis or treatment.
BIOPHEN α2-Antiplasmin (Plasmin Inhibitor) LRT
Assay proposed for the measurement of plasmin inhibitor (α2-antiplasmin) activity in research applications.
BIOPHEN Antithrombin (anti-IIa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin 2.5 (Anti-Xa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin LRT (anti-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN CS-01(38)
Chromogenic substrate for thrombin.